FDAsafety guidance72% confidence
Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Baxter.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Medical Devices · IV Administration
- Sub-indication
- General
Related signal: Baxter Faces Early Alert Over Intravascular Administration Set Air Bubble Issue